+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Digital Health In Neurology Market Size, Share & Trends Analysis Report By Component (Services, Software and Hardware), By End Use (Patients, Providers, Payers and Others), By Regional Outlook and Forecast, 2023 - 2030

  • PDF Icon

    Report

  • 174 Pages
  • March 2024
  • Region: Global
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5949681
The Global Digital Health In Neurology Market size is expected to reach $130.8 billion by 2030, rising at a market growth of 22.2% CAGR during the forecast period.

The North American healthcare system has been increasingly adopting telehealth solutions, which will likely impact neurology as well. Consequently, the North America segment captured $10,366.7 million revenue in the market in 2022. Telehealth platforms allow patients to consult with neurologists remotely, improving access to care, especially for individuals in remote or underserved areas. Hence, these segments will expand rapidly in the coming years.



Wearable devices can continuously track vital signs such as heart rate, respiratory rate, and blood pressure. For individuals with neurological disorders, changes in vital signs can provide early indications of potential issues or the effectiveness of ongoing treatments. Moreover, wearable devices with sleep monitoring capabilities offer insights into sleep patterns and disturbances. Sleep disturbances are common in neurological disorders such as epilepsy and can be important indicators for diagnosis and treatment adjustments. Some advanced wearable devices have EEG sensors that can monitor brainwave activity.

Additionally, the increasing prevalence of neurological disorders, encompassing conditions such as Alzheimer's disease, Parkinson's disease, epilepsy, and multiple sclerosis, has led to a growing demand for advanced and innovative digital health solutions. As per the data from the Pan American Health Organization (PAHO), neurological disorders caused 533,172 deaths in the Pan American Health Organization (PAHO) region in 2019, of which 320,043 (60%) were women and 213,129 (40%) were males. Digital health solutions contribute to the early detection and diagnosis of neurological disorders by integrating advanced diagnostic tools and technologies.

However, the regulatory environment for digital health applications in neurology is multifaceted, involving adherence to various regulations and standards. Obtaining reimbursement approval from insurance providers and payers is closely tied to regulatory compliance. Demonstrating the clinical and economic value of neurology applications is essential for gaining reimbursement, but this can be lengthy. Hence, these factors can hamper the demand in the market.

Moreover, the pandemic accelerated the adoption of telehealth in neurology, allowing patients to receive consultations and follow-up care remotely. Telehealth platforms became essential for maintaining continuity of care while minimizing the risk of virus transmission in healthcare settings. Digital health solutions, including remote monitoring devices and wearable technologies, gained prominence for monitoring patients with chronic neurological conditions. Remote monitoring provided healthcare professionals real-time data on patients’ vital signs, symptoms, and medication adherence, enabling proactive intervention. Thus, the COVID-19 pandemic positively impacted the market.

By End Use Analysis

On the basis of end use, the market is divided into patients, providers, payers, and others. The patients segment recorded the 36.39% revenue share in the market in 2022. Patients with neurological conditions often face challenges in traveling to healthcare facilities. Digital health enables remote monitoring and telemedicine consultations, providing convenience for patients and healthcare providers. Continuous monitoring of neurological conditions through wearable devices and at-home sensors helps track symptoms, provide timely interventions, and improve overall management.



By Component Analysis

Based on component, the market is segmented into software, hardware, and services. The software segment held a 36.25% revenue share in the market in 2022. Advanced diagnostic tools and software, such as MRI and CT scans, aid in analyzing neuroimaging data. Machine learning algorithms and artificial intelligence (AI) are increasingly being utilized to assist in the early detection and diagnosis of neurological disorders.

By Regional Analysis

By region, the market is segmented into North America, Europe, Asia Pacific, and LAMEA. In 2022, the Europe segment acquired a 38.5% revenue share in the market. Several European countries have implemented initiatives to promote digital health and enhance healthcare infrastructure. These may include funding for research and development, regulatory frameworks for digital health solutions, and technology integration into existing healthcare systems.

Market Competition and Attributes



Competition in the digital health sector within neurology is burgeoning as technological advancements continue to transform healthcare delivery. Established players and startups alike are fiercely competing to provide innovative solutions for neurological conditions, ranging from remote patient monitoring and telemedicine platforms to wearable devices and AI-driven diagnostics. Key factors driving competition include the increasing prevalence of neurological disorders, demand for personalized healthcare solutions, regulatory approvals, data security, and interoperability standards. Companies strive to differentiate themselves through superior technology, user experience, clinical efficacy, and partnerships with healthcare providers and research institutions, while navigating challenges such as data privacy concerns and reimbursement models.

Recent Strategies Deployed in the Market

  • Feb-2024: Akili, Inc.'s digital therapeutic EndeavorRx has received approval from the U.S. FDA to treat pediatric patients with attention deficit hyperactivity disorder (ADHD). This approval will improve attentional functioning in pediatric patients (aged 8-17 years) with ADHD.
  • Nov-2023: BehaVR, LLC. merged with Fern Health to introduce RealizedCare, a pioneering digital care management solution focused on chronic pain. The strategic partnership aimed to meet the rising demand for evidence-based, scalable, and economically viable solutions in mental and behavioral health.
  • Jul-2023: Big Health Inc. has acquired Limbix, the creators of the first evidence-based digital therapeutic for teens, to help millions return to good mental health. This acquisition will enable a record number of adult and adolescent patients to get immediate access to safe and effective non-drug options.
  • Mar-2023: Aural Analytics, Inc. received U.S. FDA approval for its Speech Vitals-ALS technology, a software application that collects and analyzes speech recordings to help monitor amyotrophic lateral sclerosis (ALS) in adults in clinic and home settings. This software can improve the management of this devastating disease.

List of Key Companies Profiled

  • Neofect
  • Teladoc Health, Inc.
  • Omada Health, Inc.
  • AdvancedMD, Inc.
  • Blackrock Microsystems Inc.
  • Big Health Inc.
  • BehaVR, LLC.
  • Aural Analytics, Inc.
  • AppliedVR, Inc.
  • Akili, Inc.

Market Report Segmentation

By Component
  • Services
  • Software
  • Hardware
By End Use
  • Patients
  • Providers
  • Payers
  • Others
By Geography
  • North America
  • US
  • Canada
  • Mexico
  • Rest of North America
  • Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
  • LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Digital Health In Neurology Market, by Component
1.4.2 Global Digital Health In Neurology Market, by End Use
1.4.3 Global Digital Health In Neurology Market, by Geography
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis
Chapter 4. Strategies Deployed in Digital Health In Neurology Market
Chapter 5. Global Digital Health In Neurology Market by Component
5.1 Global Services Market by Region
5.2 Global Software Market by Region
5.3 Global Hardware Market by Region
Chapter 6. Global Digital Health In Neurology Market by End Use
6.1 Global Patients Market by Region
6.2 Global Providers Market by Region
6.3 Global Payers Market by Region
6.4 Global Others Market by Region
Chapter 7. Global Digital Health In Neurology Market by Region
7.1 North America Digital Health In Neurology Market
7.1.1 North America Digital Health In Neurology Market by Component
7.1.1.1 North America Services Market by Country
7.1.1.2 North America Software Market by Country
7.1.1.3 North America Hardware Market by Country
7.1.2 North America Digital Health In Neurology Market by End Use
7.1.2.1 North America Patients Market by Country
7.1.2.2 North America Providers Market by Country
7.1.2.3 North America Payers Market by Country
7.1.2.4 North America Others Market by Country
7.1.3 North America Digital Health In Neurology Market by Country
7.1.3.1 US Digital Health In Neurology Market
7.1.3.1.1 US Digital Health In Neurology Market by Component
7.1.3.1.2 US Digital Health In Neurology Market by End Use
7.1.3.2 Canada Digital Health In Neurology Market
7.1.3.2.1 Canada Digital Health In Neurology Market by Component
7.1.3.2.2 Canada Digital Health In Neurology Market by End Use
7.1.3.3 Mexico Digital Health In Neurology Market
7.1.3.3.1 Mexico Digital Health In Neurology Market by Component
7.1.3.3.2 Mexico Digital Health In Neurology Market by End Use
7.1.3.4 Rest of North America Digital Health In Neurology Market
7.1.3.4.1 Rest of North America Digital Health In Neurology Market by Component
7.1.3.4.2 Rest of North America Digital Health In Neurology Market by End Use
7.2 Europe Digital Health In Neurology Market
7.2.1 Europe Digital Health In Neurology Market by Component
7.2.1.1 Europe Services Market by Country
7.2.1.2 Europe Software Market by Country
7.2.1.3 Europe Hardware Market by Country
7.2.2 Europe Digital Health In Neurology Market by End Use
7.2.2.1 Europe Patients Market by Country
7.2.2.2 Europe Providers Market by Country
7.2.2.3 Europe Payers Market by Country
7.2.2.4 Europe Others Market by Country
7.2.3 Europe Digital Health In Neurology Market by Country
7.2.3.1 Germany Digital Health In Neurology Market
7.2.3.1.1 Germany Digital Health In Neurology Market by Component
7.2.3.1.2 Germany Digital Health In Neurology Market by End Use
7.2.3.2 UK Digital Health In Neurology Market
7.2.3.2.1 UK Digital Health In Neurology Market by Component
7.2.3.2.2 UK Digital Health In Neurology Market by End Use
7.2.3.3 France Digital Health In Neurology Market
7.2.3.3.1 France Digital Health In Neurology Market by Component
7.2.3.3.2 France Digital Health In Neurology Market by End Use
7.2.3.4 Russia Digital Health In Neurology Market
7.2.3.4.1 Russia Digital Health In Neurology Market by Component
7.2.3.4.2 Russia Digital Health In Neurology Market by End Use
7.2.3.5 Spain Digital Health In Neurology Market
7.2.3.5.1 Spain Digital Health In Neurology Market by Component
7.2.3.5.2 Spain Digital Health In Neurology Market by End Use
7.2.3.6 Italy Digital Health In Neurology Market
7.2.3.6.1 Italy Digital Health In Neurology Market by Component
7.2.3.6.2 Italy Digital Health In Neurology Market by End Use
7.2.3.7 Rest of Europe Digital Health In Neurology Market
7.2.3.7.1 Rest of Europe Digital Health In Neurology Market by Component
7.2.3.7.2 Rest of Europe Digital Health In Neurology Market by End Use
7.3 Asia Pacific Digital Health In Neurology Market
7.3.1 Asia Pacific Digital Health In Neurology Market by Component
7.3.1.1 Asia Pacific Services Market by Country
7.3.1.2 Asia Pacific Software Market by Country
7.3.1.3 Asia Pacific Hardware Market by Country
7.3.2 Asia Pacific Digital Health In Neurology Market by End Use
7.3.2.1 Asia Pacific Patients Market by Country
7.3.2.2 Asia Pacific Providers Market by Country
7.3.2.3 Asia Pacific Payers Market by Country
7.3.2.4 Asia Pacific Others Market by Country
7.3.3 Asia Pacific Digital Health In Neurology Market by Country
7.3.3.1 China Digital Health In Neurology Market
7.3.3.1.1 China Digital Health In Neurology Market by Component
7.3.3.1.2 China Digital Health In Neurology Market by End Use
7.3.3.2 Japan Digital Health In Neurology Market
7.3.3.2.1 Japan Digital Health In Neurology Market by Component
7.3.3.2.2 Japan Digital Health In Neurology Market by End Use
7.3.3.3 India Digital Health In Neurology Market
7.3.3.3.1 India Digital Health In Neurology Market by Component
7.3.3.3.2 India Digital Health In Neurology Market by End Use
7.3.3.4 South Korea Digital Health In Neurology Market
7.3.3.4.1 South Korea Digital Health In Neurology Market by Component
7.3.3.4.2 South Korea Digital Health In Neurology Market by End Use
7.3.3.5 Singapore Digital Health In Neurology Market
7.3.3.5.1 Singapore Digital Health In Neurology Market by Component
7.3.3.5.2 Singapore Digital Health In Neurology Market by End Use
7.3.3.6 Malaysia Digital Health In Neurology Market
7.3.3.6.1 Malaysia Digital Health In Neurology Market by Component
7.3.3.6.2 Malaysia Digital Health In Neurology Market by End Use
7.3.3.7 Rest of Asia Pacific Digital Health In Neurology Market
7.3.3.7.1 Rest of Asia Pacific Digital Health In Neurology Market by Component
7.3.3.7.2 Rest of Asia Pacific Digital Health In Neurology Market by End Use
7.4 LAMEA Digital Health In Neurology Market
7.4.1 LAMEA Digital Health In Neurology Market by Component
7.4.1.1 LAMEA Services Market by Country
7.4.1.2 LAMEA Software Market by Country
7.4.1.3 LAMEA Hardware Market by Country
7.4.2 LAMEA Digital Health In Neurology Market by End Use
7.4.2.1 LAMEA Patients Market by Country
7.4.2.2 LAMEA Providers Market by Country
7.4.2.3 LAMEA Payers Market by Country
7.4.2.4 LAMEA Others Market by Country
7.4.3 LAMEA Digital Health In Neurology Market by Country
7.4.3.1 Brazil Digital Health In Neurology Market
7.4.3.1.1 Brazil Digital Health In Neurology Market by Component
7.4.3.1.2 Brazil Digital Health In Neurology Market by End Use
7.4.3.2 Argentina Digital Health In Neurology Market
7.4.3.2.1 Argentina Digital Health In Neurology Market by Component
7.4.3.2.2 Argentina Digital Health In Neurology Market by End Use
7.4.3.3 UAE Digital Health In Neurology Market
7.4.3.3.1 UAE Digital Health In Neurology Market by Component
7.4.3.3.2 UAE Digital Health In Neurology Market by End Use
7.4.3.4 Saudi Arabia Digital Health In Neurology Market
7.4.3.4.1 Saudi Arabia Digital Health In Neurology Market by Component
7.4.3.4.2 Saudi Arabia Digital Health In Neurology Market by End Use
7.4.3.5 South Africa Digital Health In Neurology Market
7.4.3.5.1 South Africa Digital Health In Neurology Market by Component
7.4.3.5.2 South Africa Digital Health In Neurology Market by End Use
7.4.3.6 Nigeria Digital Health In Neurology Market
7.4.3.6.1 Nigeria Digital Health In Neurology Market by Component
7.4.3.6.2 Nigeria Digital Health In Neurology Market by End Use
7.4.3.7 Rest of LAMEA Digital Health In Neurology Market
7.4.3.7.1 Rest of LAMEA Digital Health In Neurology Market by Component
7.4.3.7.2 Rest of LAMEA Digital Health In Neurology Market by End Use
Chapter 8. Company Profiles
8.1 Neofect
8.1.1 Company Overview
8.1.2 SWOT Analysis
8.2 Teladoc Health, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Product Launches and Product Expansions:
8.2.6 SWOT Analysis
8.3 Omada Health, Inc.
8.3.1 Company Overview
8.3.2 SWOT Analysis
8.4 AdvancedMD, Inc. (Global Payments Inc.)
8.4.1 Company Overview
8.4.2 SWOT Analysis
8.5 Blackrock Microsystems, Inc.
8.5.1 Company Overview
8.5.2 Recent strategies and developments:
8.5.2.1 Acquisition and Mergers:
8.5.2.2 Trials & Approvals:
8.5.3 SWOT Analysis
8.6 Big Health Inc.
8.6.1 Company Overview
8.6.2 Recent strategies and developments:
8.6.2.1 Acquisition and Mergers:
8.6.3 SWOT Analysis
8.7 BehaVR, Inc.
8.7.1 Company Overview
8.7.2 Recent strategies and developments:
8.7.2.1 Partnerships, Collaborations, and Agreements:
8.8 Aural Analytics, Inc.
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Partnerships, Collaborations, and Agreements:
8.8.2.2 Trials & Approvals:
8.9 AppliedVR, Inc.
8.9.1 Company Overview
8.10. Akili, Inc.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Research & Development Expenses
8.10.4 Recent strategies and developments:
8.10.4.1 Trials & Approvals:
8.10.5 SWOT Analysis
Chapter 9. Winning Imperatives of Digital Health In Neurology Market

Companies Mentioned

  • Neofect
  • Teladoc Health, Inc.
  • Omada Health, Inc.
  • AdvancedMD, Inc.
  • Blackrock Microsystems Inc.
  • Big Health Inc.
  • BehaVR, LLC.
  • Aural Analytics, Inc.
  • AppliedVR, Inc.
  • Akili, Inc.

Methodology

Loading
LOADING...